Tumor necrosis factor receptor-associated factor 5 is an essential mediator of ischemic brain infarction

Journal of Neurochemistry

Volumn 126, Issue 3, 2013, Pages 400-414

  Wang, Lang ^a,b   Lu, Yanyun ^a,b   Guan, Hongjing ^a,b   Jiang, Dingsheng ^a,b   Guan, Yu ^c   Zhang, Xin ^a,b   Nakano, Hiroyasu ^d   Zhou, Yan ^b   Zhang, Yan ^a,b   Yang, Li ^a,b   Li, Hongliang ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c TONGJI HOSPITAL OF TONGJI MEDICAL COLLEGE OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d JUNTENDO UNIVERSITY   (Japan)

Author keywords

Akt; apoptosis; blood brain barrier; inflammation; stroke; TRAF5

Indexed keywords

CASPASE 3; FAS ANTIGEN; FAS LIGAND; GELATINASE A; GELATINASE B; I KAPPA B ALPHA; I KAPPA B KINASE BETA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

AKT; APOPTOSIS; BLOOD-BRAIN BARRIER; INFLAMMATION; STROKE; TRAF5;

ANIMALS; BLOTTING, WESTERN; BRAIN INFARCTION; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; IN SITU NICK-END LABELING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 5;

MUS;

EID: 84880569986     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12207     Document Type: Article

References (50)

1. Akiba H., Nakano H., Nishinaka S., et al,. (1998) CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J. Biol. Chem. 273, 13353-13358.
2. Asahi M., Wang X., Mori T., Sumii T., Jung J. C., Moskowitz M. A., Fini M. E., and, Lo E. H., (2001) Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724-7732.
3. Au P. Y, and, Yeh W. C., (2007) Physiological roles and mechanisms of signaling by TRAF2 and TRAF5. Adv. Exp. Med. Biol. 597, 32-47.
4. Baldwin K., Orr S., Briand M., Piazza C., Veydt A., and, McCoy S., (2010) Acute ischemic stroke update. Pharmacotherapy 30, 493-514.
5. Bradley J. R., and, Pober J. S., (2001) Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20, 6482-6491.
6. Bronner L. L, Kanter D. S, and, Manson J. E., (1995) Primary prevention of stroke. N. Engl. J. Med. 333, 1392-1400.
7. Brouns R., and, De Deyn P. P., (2009) The complexity of neurobiological processes in acute ischemic stroke. Clin. Neurol. Neurosurg. 111, 483-495.
8. Brown J., Wang H., Suttles J., Graves D. T, and, Martin M., (2011) Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response via FoxO1. J. Biol. Chem. 286, 44295-44305.
9. Clark K., Takeuchi O., Akira S., and, Cohen P., (2011) The TRAF-associated protein TANK facilitates cross-talk within the IkappaB kinase family during Toll-like receptor signaling. Proc. Natl Acad. Sci. USA 108, 17093-17098.
10. Dimitrijevic O. B, Stamatovic S. M, Keep R. F, and, Andjelkovic A. V., (2006) Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury. J. Cereb. Blood Flow Metab. 26, 797-810.
11. Donners M. M., Beckers L., Lievens D., et al,. (2008) The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling. Blood 111, 4596-4604.
12. Doyle K. P., Simon R. P., and, Stenzel-Poore M. P., (2008) Mechanisms of ischemic brain damage. Neuropharmacology 55, 310-318.
13. Engel D., Seijkens T., Poggi M., Sanati M., Thevissen L., Beckers L., Wijnands E., Lievens D., and, Lutgens E., (2009) The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis. Semin. Immunol. 21, 308-312.
14. Fan W., Morinaga H., Kim J. J., Bae E., Spann N. J., Heinz S., Glass C. K., and, Olefsky J., (2010) M. FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages. EMBO J. 29, 4223-4236.
15. Feng S., Cen J., Huang Y., Shen H., Yao L., Wang Y., and, Chen Z., (2011) Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS ONE 6, e20599.
16. Huan W., Wu X., Zhang S., Zhao Y., Xu H., Wang N., Li H., Chen H., Wei H., and, Wang Y., (2012) Spatiotemporal patterns and essential role of TNF receptor-associated factor 5 expression after rat spinal cord injury. J. Mol. Histol. 43, 527-533.
17. Ishida T. K., Tojo T., Aoki T., Kobayashi N., Ohishi T., Watanabe T., Yamamoto T., and, Inoue J., (1996) TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl Acad. Sci. USA 93, 9437-9442.
18. Ito Y., Daitoku H., and, Fukamizu A., (2009) Foxo1 increases pro-inflammatory gene expression by inducing C/EBPbeta in TNF-alpha-treated adipocytes. Biochem. Biophys. Res. Commun. 378, 290-295.
19. Jin R., Yang G., and, Li G., (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 87, 779-789.
20. Jung J. E., Kim G. S., Chen H., et al,. (2010) Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol. Neurobiol. 41, 172-179.
21. Kraus Z. J, Haring J. S, and, Bishop G. A., (2008) TNF receptor-associated factor 5 is required for optimal T cell expansion and survival in response to infection. J. Immunol. 181, 7800-7809.
22. Lakhan S. E, Kirchgessner A., and, Hofer M., (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med. 7, 97.
23. Lu H., Liu P., Pan Y., and, Huang H., (2011) Inhibition of cyclin-dependent kinase phosphorylation of FOXO1 and prostate cancer cell growth by a peptide derived from FOXO1. Neoplasia 13, 854-863.
24. Lutgens E., Lievens D., Beckers L., et al,. (2010) Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J. Exp. Med. 207, 391-404.
25. McColl B. W, Rothwell N. J, and, Allan S. M., (2008) Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci. 28, 9451-9462.
26. Missiou A., Rudolf P., Stachon P., et al,. (2010) TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation. Circ. Res. 107, 757-766.
27. Murray V., Norrving B., Sandercock P. A., Terent A., Wardlaw J. M., and, Wester P., (2010) The molecular basis of thrombolysis and its clinical application in stroke. J. Intern. Med. 267, 191-208.
28. Nakano H., Oshima H., Chung W., Williams-Abbott L., Ware C. F., Yagita H., and, Okumura K., (1996) TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor. J. Biol. Chem., 271, 14661-14664.
29. Nakano H., Sakon S., Koseki H., et al,. (1999) Targeted disruption of TRAF5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. Proc. Natl Acad. Sci. USA 96, 9803-9808.
30. Oh L. Y, Larsen P. H., Krekoski C. A., Edwards D. R., Donovan F., Werb Z., and, Yong V. W., (1999) Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J. Neurosci. 19, 8464-8475.
31. Rosell A., Cuadrado E., Ortega-Aznar A., Hernández-Guillamon M., Lo E. H., and, Montaner J., (2008) MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke 39, 1121-1126.
32. Saitoh T., Nakano H., Yamamoto N., and, Yamaoka S., (2002) Lymphotoxin-beta receptor mediates NEMO-independent NF-kappaB activation. FEBS Lett. 532, 45-51.
33. Saitoh T., Nakayama M., Nakano H., Yagita H., Yamamoto N., and, Yamaoka S., (2003) TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. J. Biol. Chem. 278, 36005-36012.
34. Sandoval K. E, and, Witt K. A., (2008) Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol. Dis. 32, 200-219.
35. Supanc V., Biloglav Z., Kes V. B., and, Demarin V., (2011) Role of cell adhesion molecules in acute ischemic stroke. Ann. Saudi Med. 31, 365-370.
36. Tang E. D, and, Wang C. Y., (2010) TRAF5 is a downstream target of MAVS in antiviral innate immune signaling. PLoS ONE 5, e9172.
37. Tao T., Cheng C., Ji Y., Xu G., Zhang J., Zhang L., and, Shen A., (2012) Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-κB activation. Mol. Biol. Cell 23, 2635-2644.
38. Terao S., Yilmaz G., Stokes K. Y., Russell J., Ishikawa M., Kawase T., and, Granger D. N., (2008) Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion Stroke 39, 2560-2570.
39. Tu J. V., (2010) Reducing the global burden of stroke: INTERSTROKE. Lancet 376, 74-75.
40. Uyama O., Okamura N., Yanase M., Narita M., Kawabata K., and, Sugita M., (1988) Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J. Cereb. Blood Flow Metab. 8, 282-284.
41. Wang L., Lu Y., Deng S., Zhang Y., Yang L., Guan Y, Matozaki T., Ohnishi H., Jiang H., and, Li H., (2012a) SHPS-1 deficiency induces robust neuroprotection against experimental stroke by attenuating oxidative stress. J. Neurochem. 122, 834-843.
42. Wang L., Deng S., Lu Y., Zhang Y., Yang L., Guan Y., Jiang H., and, Li H., (2012b) Increased inflammation and brain injury after transient focal cerebral ischemia in activating transcription factor 3 knockout mice. Neuroscience 220, 100-108.
43. Won C. K, Ji H. H, and, Koh P. O., (2006) Estradiol prevents the focal cerebral ischemic injury-induced decrease of forkhead transcription factors phosphorylation. Neurosci. Lett. 398, 39-43.
44. Xie P., Poovassery J., Stunz L. L., Smith S. M, Schultz M. L., Carlin L. E, and, Bishop G. A., (2011) Enhanced Toll-like receptor (TLR) responses of TNFR-associated factor 3 (TRAF3)-deficient B lymphocytes. J. Leukoc. Biol. 90, 1149-1157.
45. Yang Y., Candelario-Jalil E., Thompson J. F., Cuadrado E., Estrada E. Y., Rosell A., Montaner J., and, Rosenberg G. A., (2010) Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia. J. Neurochem. 112, 134-149.
46. Zhan L., Wang T., Li W., Xu Z. C., Sun W., and, Xu E., (2010) Activation of Akt/FoxO signaling pathway contributes to induction of neuroprotection against transient global cerebral ischemia by hypoxic pre-conditioning in adult rats. J. Neurochem. 114, 897-908.
47. Zhou Q., and, Geahlen R. L., (2009) The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells. Oncogene 28, 1348-1356.
48. Zirlik A., Bavendiek U., Libby P., et al,. (2007) TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 27, 1101-1107.
49. del Zoppo G. J, Frankowski H., Gu Y. H., Osada T., Kanazawa M., Milner R., Wang X., Hosomi N., Mabuchi T., and, Koziol J. A., (2012) Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation. J. Cereb. Blood Flow Metab. 32, 919-932.
50. Zotti T., Vito P., and, Stilo R., (2012) The seventh ring: exploring TRAF7 functions. J. Cell. Physiol. 227, 1280-1284.